These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2476492)

  • 41. T cell memory. Long-term persistence of virus-specific cytotoxic T cells.
    Jamieson BD; Ahmed R
    J Exp Med; 1989 Jun; 169(6):1993-2005. PubMed ID: 2471771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo.
    Pircher H; Moskophidis D; Rohrer U; Bürki K; Hengartner H; Zinkernagel RM
    Nature; 1990 Aug; 346(6285):629-33. PubMed ID: 1696684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Persistent infection with lymphocytic choriomeningitis virus enhances expression of MHC class I glycoprotein on cultured mouse brain endothelial cells.
    Gairin JE; Joly E; Oldstone MB
    J Immunol; 1991 Jun; 146(11):3953-7. PubMed ID: 2033264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus.
    Moskophidis D; Zinkernagel RM
    J Virol; 1995 Apr; 69(4):2187-93. PubMed ID: 7533851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
    van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
    Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo.
    Byrne JA; Oldstone MB
    J Virol; 1984 Sep; 51(3):682-6. PubMed ID: 6332201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology.
    Battegay M; Oehen S; Schulz M; Hengartner H; Zinkernagel RM
    J Virol; 1992 Feb; 66(2):1199-201. PubMed ID: 1370548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Numbers of cytolytic T lymphocytes (CTL) and CTL precursor cells in spleens of mice acutely infected with lymphocytic choriomeningitis virus.
    Assmann-Wischer U; Moskophidis D; Simon MM; Lehmann-Grube F
    Med Microbiol Immunol; 1986; 175(2-3):141-3. PubMed ID: 3487706
    [No Abstract]   [Full Text] [Related]  

  • 49. Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo.
    Klavinskis LS; Geckeler R; Oldstone MB
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3317-25. PubMed ID: 2514255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell-mediated immune response to lymphocytic choriomeningitis and vaccinia virus in rats.
    Zinkernagel RM; Althage A; Jensen FC
    J Immunol; 1977 Oct; 119(4):1242-7. PubMed ID: 408419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.
    Lukacher AE; Braciale VL; Braciale TJ
    J Exp Med; 1984 Sep; 160(3):814-26. PubMed ID: 6206190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions between viruses and lymphocytes. I. In vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infections.
    Doyle MV; Oldstone MB
    J Immunol; 1978 Oct; 121(4):1262-9. PubMed ID: 308960
    [No Abstract]   [Full Text] [Related]  

  • 53. Absence of CTL responses to early viral antigens facilitates viral persistence.
    Schildknecht A; Welti S; Geuking MB; Hangartner L; van den Broek M
    J Immunol; 2008 Mar; 180(5):3113-21. PubMed ID: 18292534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. III. In vivo protective activity of effector cells generated in vitro.
    Dunlop MB
    Immunology; 1978 Feb; 34(2):291-302. PubMed ID: 304841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How can we stimulate the immune system in vivo?
    Zinkernagel RM
    Dev Biol Stand; 1992; 77():29-30. PubMed ID: 1426669
    [No Abstract]   [Full Text] [Related]  

  • 56. Novel LCMV-specific H-2k restricted CTL clones recognize internal viral gene products and cause CNS disease.
    Lewicki H; McKee TA; Tishon A; Salvato M; Whitton JL; Oldstone MB
    J Neuroimmunol; 1992 Nov; 41(1):15-20. PubMed ID: 1281166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alterations of a dominant epitope of lymphocytic choriomeningitis virus which affect class I binding and cytotoxic T cell recognition.
    Hioe CE; Frelinger JA
    Mol Immunol; 1995 Jul; 32(10):725-31. PubMed ID: 7544868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cloned cytotoxic T cells specific for lymphocytic choriomeningitis virus induce acute disease and primary footpad swelling in infected mice.
    Baenziger J; Hengartner H; Zinkernagel RM
    Med Microbiol Immunol; 1986; 175(2-3):201-3. PubMed ID: 3487709
    [No Abstract]   [Full Text] [Related]  

  • 59. Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses.
    Ludewig B; Jäggi M; Dumrese T; Brduscha-Riem K; Odermatt B; Hengartner H; Zinkernagel RM
    J Immunol; 2001 Mar; 166(5):3369-76. PubMed ID: 11207293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of recovery from acute virus infection. III. Subclass of T lymphocytes mediating clearance of lymphocytic choriomeningitis virus from the spleens of mice.
    Assmann-Wischer U; Simon MM; Lehmann-Grube F
    Med Microbiol Immunol; 1985; 174(5):249-56. PubMed ID: 3878930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.